JP2017531801A5 - - Google Patents

Download PDF

Info

Publication number
JP2017531801A5
JP2017531801A5 JP2017518834A JP2017518834A JP2017531801A5 JP 2017531801 A5 JP2017531801 A5 JP 2017531801A5 JP 2017518834 A JP2017518834 A JP 2017518834A JP 2017518834 A JP2017518834 A JP 2017518834A JP 2017531801 A5 JP2017531801 A5 JP 2017531801A5
Authority
JP
Japan
Prior art keywords
antibody
cdtb
level
vinculin
ibs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017518834A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017531801A (ja
JP6784669B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/054655 external-priority patent/WO2016057772A1/en
Publication of JP2017531801A publication Critical patent/JP2017531801A/ja
Publication of JP2017531801A5 publication Critical patent/JP2017531801A5/ja
Application granted granted Critical
Publication of JP6784669B2 publication Critical patent/JP6784669B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017518834A 2014-10-09 2015-10-08 炎症性腸疾患及びセリアック病から過敏性腸症候群を識別するための方法及びシステム Active JP6784669B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462061877P 2014-10-09 2014-10-09
US62/061,877 2014-10-09
US201462085825P 2014-12-01 2014-12-01
US62/085,825 2014-12-01
PCT/US2015/054655 WO2016057772A1 (en) 2014-10-09 2015-10-08 Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease

Publications (3)

Publication Number Publication Date
JP2017531801A JP2017531801A (ja) 2017-10-26
JP2017531801A5 true JP2017531801A5 (enExample) 2017-12-07
JP6784669B2 JP6784669B2 (ja) 2020-11-11

Family

ID=55653760

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017518834A Active JP6784669B2 (ja) 2014-10-09 2015-10-08 炎症性腸疾患及びセリアック病から過敏性腸症候群を識別するための方法及びシステム

Country Status (16)

Country Link
US (2) US10132814B2 (enExample)
EP (1) EP3204771B1 (enExample)
JP (1) JP6784669B2 (enExample)
KR (1) KR102426541B1 (enExample)
CN (1) CN107003308B (enExample)
AU (1) AU2015330872B2 (enExample)
CA (1) CA2962493C (enExample)
ES (1) ES3028294T3 (enExample)
IL (1) IL251606B (enExample)
MX (1) MX384921B (enExample)
NZ (1) NZ730490A (enExample)
PL (1) PL3204771T3 (enExample)
PT (1) PT3204771T (enExample)
RU (1) RU2706361C2 (enExample)
SG (1) SG11201702395WA (enExample)
WO (1) WO2016057772A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11693009B2 (en) 2009-02-11 2023-07-04 Cedars-Sinai Medical Center Methods for detecting post-infectious irritable bowel syndrome
MX348670B (es) 2009-02-11 2017-06-23 Cedars Sinai Medical Center Anticuerpo contra toxina de distensión citoletal de campylobacter jejuni.
KR102203568B1 (ko) 2012-09-17 2021-01-15 세다르스-신나이 메디칼 센터 장 및 방광의 운동 장애 및 섬유근육통의 진단 및 치료
CA2923651C (en) 2013-10-09 2023-03-14 Cedars-Sinai Medical Center Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease
AU2015330872B2 (en) 2014-10-09 2021-04-22 Cedars-Sinai Medical Center Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease
AU2018212924A1 (en) 2017-01-30 2019-07-04 Cedars-Sinai Medical Center Diagnosis of scleroderma
EP3913371A1 (en) 2020-05-18 2021-11-24 Neuroimmun GmbH Method and kit for diagnosting irritable bowel syndrome and for its relief through dietary interventions
CN113447649B (zh) * 2021-07-01 2022-04-19 浙江大学 一种检测抗粘着斑蛋白-IgG抗体的试剂盒

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5691151A (en) 1994-10-07 1997-11-25 Regents Of University Of California Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
FR2806805A1 (fr) 2000-03-22 2001-09-28 Centre Nat Rech Scient SEQUENCE PEPTIDIQUES COMPRENANT UN OU PLUSIEURS MOTIFS DE LIAISON AUX PROTEINES DE LA FAMILLE Ena/VASP, ET LEURS UTILISATIONS
US20040018528A1 (en) 2002-05-17 2004-01-29 Sugen, Inc. Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals
EP1578364A4 (en) 2002-09-16 2011-06-08 Genentech Inc COMPOSITIONS AND METHOD FOR THE TREATMENT OF ILLNESSES OF THE IMMUNE SYSTEM
US7595386B2 (en) 2003-01-24 2009-09-29 William Beaumont Hospital Methods and compositions for heat activated gene therapy using cytolethal distending toxin
JP2006522817A (ja) * 2003-04-08 2006-10-05 プロジェニックス ファーマシューティカルズ,インコーポレーテッド 過敏性腸症候群を処置するための末梢オピオイドアンタゴニスト、特にメチルナルトレキソンの使用
US20060094056A1 (en) 2003-09-15 2006-05-04 Oklahoma Medical Research Foundation Method of using cytokine assays to diagnose treat, and evaluate inflammatory and autoimmune diseases
EP1698698B1 (en) 2003-12-05 2014-02-12 Fuso Pharmaceutical Industries, Ltd. Cytolethal distending toxin genes as targets for the detection of campylobacter bacteria
US20080085524A1 (en) 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
US8148067B2 (en) 2006-11-09 2012-04-03 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
ES2391792T3 (es) 2007-12-20 2012-11-29 Index Diagnostics Ab (Publ) Método para la diferenciación de EII y SII y la distinción adicional entre tipos patológicos de EII
WO2010045180A1 (en) 2008-10-13 2010-04-22 Metabolon, Inc. Biomarkers for inflammatory bowel disease and methods using the same
WO2010060098A1 (en) 2008-11-24 2010-05-27 Cedars-Sinai Medical Center Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof
MX348670B (es) 2009-02-11 2017-06-23 Cedars Sinai Medical Center Anticuerpo contra toxina de distensión citoletal de campylobacter jejuni.
US20110294726A1 (en) 2009-02-11 2011-12-01 Cedars-Sinai Medical Center Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome
FR2942541A1 (fr) 2009-02-25 2010-08-27 Assist Publ Hopitaux De Paris Procede de diagnostic d'une vascularite
RU2397178C1 (ru) * 2009-02-27 2010-08-20 Федеральное государственное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Диагностическая тест-система в формате иммуночипа и способ серологической дифференциальной диагностики сифилиса
IT1400989B1 (it) 2010-07-13 2013-07-05 Segix Italia S R L Ora Istituto Biochimico Naz Savio S R L Forme di somministrazione orale a rilascio controllato di rifampicina per il trattamento di infezioni batteriche dell' apparato intestinale.
GB201017520D0 (en) 2010-10-15 2010-12-01 Sense Proteomic Ltd Biomarkers
JP5477671B2 (ja) 2012-02-28 2014-04-23 三菱マテリアル株式会社 サーミスタ用金属窒化物材料及びその製造方法並びにフィルム型サーミスタセンサ
KR102203568B1 (ko) * 2012-09-17 2021-01-15 세다르스-신나이 메디칼 센터 장 및 방광의 운동 장애 및 섬유근육통의 진단 및 치료
CA2923651C (en) 2013-10-09 2023-03-14 Cedars-Sinai Medical Center Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease
AU2015330872B2 (en) 2014-10-09 2021-04-22 Cedars-Sinai Medical Center Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease
AU2018212924A1 (en) 2017-01-30 2019-07-04 Cedars-Sinai Medical Center Diagnosis of scleroderma

Similar Documents

Publication Publication Date Title
JP6452718B2 (ja) 食物アレルギーを検出するためのペプチド、試薬及び方法
RU2017115663A (ru) Способы и системы для отличия синдрома раздраженного кишечника от воспалительного заболевания кишечника и глютеновой болезни
JP2016507066A5 (enExample)
JP2022160422A (ja) エキソソームの亜集団の定量および神経変性障害の診断
JP2014524744A5 (enExample)
JP2016500659A5 (enExample)
JP2017505436A5 (enExample)
JP2015517801A5 (enExample)
JP6440719B2 (ja) 腎疾患のバイオマーカー
JP2016500815A5 (enExample)
JP2016511406A (ja) アルツハイマー病の診断のための方法と組成物
JP2010522875A5 (enExample)
JP2016516008A5 (enExample)
JP2017532577A5 (enExample)
JP2013539032A5 (enExample)
RU2018103933A (ru) Моноклональные антитела, с ориентировкой на антиген Р респираторно-синцитиального вируса человека, получаемые и секретируемые из клеточных гибридом, используемые для обнаружения и диагностики инфекции, вызываемой респираторно-синцитиальным вирусом
JP2020016660A (ja) クロモグラニンaを検出するための免疫アッセイ法および抗体
RU2019113127A (ru) REP белок в качестве белкового антигена для диагностических анализов
CN110716050A (zh) 抗原组合在制备用于肺癌相关自身抗体检测的试剂盒中的用途以及相应的试剂盒和检测方法
JP2015514707A5 (enExample)
JP2013506837A5 (enExample)
JP2023551327A (ja) 血液由来エクソソームから見出した新規アルツハイマー病診断用バイオマーカー及びそれを用いたアルツハイマー病診断方法
JP2014524583A5 (enExample)
RU2019110953A (ru) Моноклональное антитело, специфически связывающееся с тиоредоксином-1, и его применение
JP2017524933A5 (enExample)